JPWO2012147705A1 - トレハロースを含有する炎症性呼吸器疾患の治療剤 - Google Patents
トレハロースを含有する炎症性呼吸器疾患の治療剤 Download PDFInfo
- Publication number
- JPWO2012147705A1 JPWO2012147705A1 JP2013512360A JP2013512360A JPWO2012147705A1 JP WO2012147705 A1 JPWO2012147705 A1 JP WO2012147705A1 JP 2013512360 A JP2013512360 A JP 2013512360A JP 2013512360 A JP2013512360 A JP 2013512360A JP WO2012147705 A1 JPWO2012147705 A1 JP WO2012147705A1
- Authority
- JP
- Japan
- Prior art keywords
- trehalose
- ova
- therapeutic agent
- respiratory diseases
- inflammatory respiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
市販されている吸入ステロイド剤には,ラクトースが含まれている。このため,ラクトースと比較してトレハロースが気道抵抗や気道コンプライアンスの点で優れているか否かについて検討した。
Claims (5)
- トレハロース又はトレハロースの誘導体を有効成分として含有する炎症性呼吸器疾患の治療剤。
- 請求項1に記載の治療剤であって,
前記炎症性呼吸器疾患が気管支喘息である,
治療剤。 - 請求項1に記載の治療剤であって,
ステロイド,抗生物質,非ステロイド系消炎鎮痛剤,及び抗ヒスタミン剤のいずれか又は2種以上をさらに含む,
治療剤。 - トレハロース又はトレハロースの誘導体を有効成分として含有する気道狭窄抑制剤。
- トレハロース又はトレハロースの誘導体を有効成分として含有するアレルギー性疾患の治療剤。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011096657 | 2011-04-24 | ||
JP2011096657 | 2011-04-24 | ||
PCT/JP2012/060893 WO2012147705A1 (ja) | 2011-04-24 | 2012-04-23 | トレハロースを含有する炎症性呼吸器疾患の治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2012147705A1 true JPWO2012147705A1 (ja) | 2014-07-28 |
Family
ID=47072224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013512360A Pending JPWO2012147705A1 (ja) | 2011-04-24 | 2012-04-23 | トレハロースを含有する炎症性呼吸器疾患の治療剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2012147705A1 (ja) |
WO (1) | WO2012147705A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018188408A (ja) * | 2017-05-11 | 2018-11-29 | 国立大学法人群馬大学 | 制御性t細胞増強剤並びにそれを含む医薬及び食品組成物 |
EP4125927A4 (en) * | 2020-04-17 | 2023-12-13 | Next21 Kabushiki Kaisha | MEDICINAL PRODUCT CONTAINING TREHALOSE OR A TREHALOSE DERIVATIVE AND NASAL SPRAY |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006316053A (ja) * | 2005-04-13 | 2006-11-24 | Hayashibara Biochem Lab Inc | 細胞障害抑制剤とその用途 |
WO2007111214A1 (ja) * | 2006-03-27 | 2007-10-04 | Otsuka Chemical Co., Ltd. | トレハロース化合物および該化合物を含有する医薬 |
JP2010150294A (ja) * | 2010-03-26 | 2010-07-08 | Kao Corp | S100a8発現調節剤 |
-
2012
- 2012-04-23 WO PCT/JP2012/060893 patent/WO2012147705A1/ja active Application Filing
- 2012-04-23 JP JP2013512360A patent/JPWO2012147705A1/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006316053A (ja) * | 2005-04-13 | 2006-11-24 | Hayashibara Biochem Lab Inc | 細胞障害抑制剤とその用途 |
WO2007111214A1 (ja) * | 2006-03-27 | 2007-10-04 | Otsuka Chemical Co., Ltd. | トレハロース化合物および該化合物を含有する医薬 |
JP2010150294A (ja) * | 2010-03-26 | 2010-07-08 | Kao Corp | S100a8発現調節剤 |
Non-Patent Citations (2)
Title |
---|
JPN6012025367; 消化と吸収 VOL.26, NO.2, 2004, P.26-29 * |
JPN6012025368; JOURNAL OF HEALTH SCIENCE VOL.54, NO.1, 2008, P.76-80 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012147705A1 (ja) | 2012-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2664175T3 (es) | Formulación de polvo seco que comprende un inhibidor de fosfodiesterasa | |
AU2019200171B2 (en) | Thiosaccharide mucolytic agents | |
JP6707076B2 (ja) | アルギネートオリゴマーの吸入可能粉末製剤 | |
JP6396544B2 (ja) | エクトインの治療的使用 | |
JP2012197306A (ja) | 呼吸器疾患の治療のためのシクレソニドの使用 | |
EP1796679A1 (en) | Ciclesonide and syk inhibitor combination and methods of use thereof | |
KR20080069196A (ko) | 글리코피로늄 염을 포함하는 유기 화합물 | |
JP2011528355A (ja) | 充血除去剤およびコルチコステロイドを含む鼻腔内粗製物 | |
WO2021229514A1 (en) | Pharmaceutical ivermectin compositions | |
EP2934479B1 (en) | Ciclesonide for the treatment of airway disease in horses | |
AU2015204531B2 (en) | Pharmaceutical compositions comprising 15-HEPE and methods of treating asthma and lung disorders using same | |
AU2015261103A1 (en) | Combinations of tiotropium bromide, formoterol and budesonide for the treatment of COPD | |
EA012388B1 (ru) | Водные суспензии циклесонида для аэрозольного распыления | |
KR20180118667A (ko) | 만성 폐쇄성 폐 질환의 급성 악화 치료를 위한 투약법 | |
WO2012147705A1 (ja) | トレハロースを含有する炎症性呼吸器疾患の治療剤 | |
JP2008110991A (ja) | 処置方法 | |
JP2022500380A (ja) | ジチオール糖粘液剤およびその使用 | |
JP2007533706A (ja) | 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用 | |
US20180243257A1 (en) | Combination of furosemide and steroids and uses therefor | |
WO2021210648A1 (en) | Medicine containing trehalose or trehalose derivative and nasal spray | |
JP2007533706A5 (ja) | ||
RU2013148786A (ru) | Улучшенный состав суспензии кортикостероида для ингаляционного введения | |
JP2017066075A (ja) | リウマチ治療薬 | |
Jayanna et al. | Clinical features, diagnosis and management of oral lichen planus in children | |
ES2471139T3 (es) | Combinaciones ventajosas para la inhalaci�n de nacistelina y broncodilatadores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150319 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20151119 |
|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20151119 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160216 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160809 |